An AMPK activator, Metformin, ameliorates aging-related oxidative hepatic injury induced by D-galactose via Irisin/ SIRT1 pathway, a possible role of PPAR-γ besides its antioxida - Egyptian Knowledge Bank

382458

An AMPK activator, Metformin, ameliorates aging-related oxidative hepatic injury induced by D-galactose via Irisin/ SIRT1 pathway, a possible role of PPAR-γ besides its antioxida

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

Targeting PPARγ/ Irisin pathway in the potential effect of metformin on D-galactose-induced hepatic aging in rats.

Article

Metformin: An AMPK-dependent antidiabetic drug with novel medical applications

Article

Resveratrol and/or Metformin Activates Serum Sirtuin-1 and Decreases Insulin Resistance in High Fructose-Fed Rats

Article

METFORMIN ATTENUATES THIOACETAMIDE INDUCED HEPATOTOXIC EFFECTS IN RATS

Article

Effects of Curcumin on Autophagy and Nrf2 signaling pathway in a Rat Model of High fructose diet induced Steatohepatitis

Article

Effects of Activation of GHSR1a on Hepatic Fibrosis in Type 2 Diabetic Rats.

Article

Mechanistic study on the metformin treatment effect on the oxidative stress caused by doxorubicin in albino rat liver

Article

Effect of Quercetin and Metformin on Glucose Transporter-4 Expression, Oxidative Stress, Inflammation Markers and Insulin Resistance in Type 2 Diabetes Mellitus

Article

CARDIOPROTECTIVE INFLUENCE OF METFORMIN ON DOXORUBICIN-INDUCED CARDIOMYOPATHY: THE IMPLICATION OF MITOCHONDRIAL DYNAMICS

Article

Exercise rescues cognitive deterioration in naturally aged rats via PGC1α/FNDC5/irisin/AMPK signaling pathway to restore redox, endothelial, and neuronal homeostasis